Indevus Pharmaceuticals About
Indevus Pharmaceuticals Indevus acquires, develop and commercialize
products for multiple theraputic areas, with a primary commitment to urology,
gynecology and infectious diseases. With the recent launch of their lead
product, SANCTURA™ for overactive bladder, they have established
a sales and marketing infrastructure. They believe this expansion positions them
strongly as a partner of choice for companies and research institutions seeking
a collaborator with the proven ability to accomplish the development and commercialization
of a broad array of biopharmaceutical products in a timely and efficient manner.
SANCTURA -- Overactive
Bladder -- Marketed Pagoclone--
Anxiety and Stuttering PRO2000--
HIV and STD Prevention IP751
-- Pain and
Inflammation Aminocandin -- Fungal
Infection Sarafem -- Premenstrual Dysphoric Disorder
-- Marketed More
on Indevus Key
Statistics for Indevus
Basic
Chart for Indevus